PROVIDER FILE · The cost notebook

Texas Weight Loss Review: What the Visit Fees and Semaglutide Price Actually Cover

Texas Weight Loss publishes a $150 initial visit, $110 monthly follow-ups and semaglutide at $100–$275 for a monthly supply depending on dosage. Those are separate price disclosures—not a documented all-inclusive treatment total.

Texas Weight Loss gives prospective patients several concrete prices, but not one complete bill. Its $150 initial appointment, $110 monthly follow-up and $100–$275 monthly semaglutide supply describe different parts of care. The important budgeting question is how those parts fit together for the treatment actually prescribed. A medication price alone cannot answer that, especially when the provider explicitly says medication costs extra and does not explain every possible testing, dispensing or delivery charge.

This documentary review examines Texas Weight Loss’s public materials consulted October 19, 2026. The provider advertises medical weight management across six Texas locations, including Houston-area clinics, Austin and San Antonio, along with injectable semaglutide and tirzepatide, oral phentermine and nutritional support. Its disclosures offer a useful starting point for comparing costs, but leave consequential questions about the exact semaglutide formulation, pharmacy, payment arrangements and ongoing obligations. The practical task is to turn the posted menu into a patient-specific written quote—not to treat the lowest listed medication price as the whole program.

At a glance

Initial appointment
$150, with a medical consultation, specified laboratory work, body-composition analysis, four energy-boosting shots and dietary materials listed.
Sources: [9]
Ongoing visits
$110 for a monthly follow-up, including consultation, an appetite-suppressant prescription if medically indicated and four energy-boosting shots; a prescription is not the medication itself.
Sources: [9]
Semaglutide price
$100–$275 for a monthly supply depending on dosage; the disclosure does not establish an all-inclusive program price.
Sources: [9]
Formulation and sourcing
Spanish-language pages describe semaglutide with glycine and sourcing from an unnamed 503b compounding pharmacy, without establishing that the posted price applies to that exact formulation.
Sources: [11] [7]
Service footprint
The provider claims six Texas locations and describes clinics in Austin, San Antonio and the Houston area; its after-hours telemedicine announcement is expressly limited to Texas residents.
Sources: [6] [3]

Read the price menu as separate charges

The clearest financial disclosure is the distinction between an appointment and medication. Texas Weight Loss lists an initial weight-loss visit at $150 and a monthly follow-up at $110. Separately, it lists semaglutide at $100–$275 for a monthly supply, depending on dosage. The initial-visit listing expressly says prescription eligibility is determined at the appointment and medication is an additional charge. That language prevents a reasonable reading of the visit fee as automatically buying a month of GLP-1 treatment.

The figures below are published line items, not a combined estimate. The materials do not establish whether every semaglutide patient follows exactly the same appointment and payment arrangement, or whether additional testing could apply. There is also no published tirzepatide price in the supplied evidence. Before paying, request the amount due for evaluation and the separate amount due if medication is prescribed. Our guide to why the first payment can differ from the monthly price explains why those two figures should be obtained together.

Published Texas Weight Loss prices, without assuming a bundled treatment total
ItemPublished chargeImportant boundary
Initial weight-loss visit$150Medication is an additional charge; prescription eligibility is determined at the visit.
Monthly follow-up visit$110Lists a prescription if medically indicated, not included medication.
Semaglutide$100–$275 for a monthly supply, depending on dosageDoes not establish inclusion of visits or identify the priced formulation.
Energy-boosting shots$20 each or $60 for fourFour are also listed with the initial and follow-up visits.
“Fat Burner” shots$25 each or $80 for fourThe four-shot listing carries a “buy three get one free” footnote.
Standalone body-composition analysis$25Body-composition analysis is also listed within the initial visit.
Sources: [9]

What the first $150 is documented to buy

The initial appointment has a comparatively detailed inclusion list. It names a medical consultation, a comprehensive metabolic panel, thyroid-stimulating hormone testing, a lipid panel, HbA1c and body-composition analysis. Elsewhere, the provider describes first-visit blood testing in terms of liver, kidney and thyroid function. These descriptions help explain the evaluation component of the fee. They do not establish that every test a clinician might subsequently request is included, or that paying the fee guarantees a prescription.

The same $150 listing includes four energy-boosting shots, a diet menu, a meal plan and a pantry-makeover guide. The broader FAQ says meal planning reflects lifestyle and dietary preferences and includes lists of approved and unapproved foods. These are documented program components, but the supplied materials do not describe the shots’ exact contents in that package, substitution options or a discount for declining them. Someone comparing clinics should distinguish services they expect to use from items merely bundled into the advertised appointment. An itemized confirmation would make that comparison more meaningful.

Sources: [12] [3] [9]

Monthly follow-up is a care charge, not a refill price

Texas Weight Loss asks patients to attend monthly follow-ups to track progress, discuss results and adjust the plan as needs change. Its $110 follow-up listing includes a medical consultation, an appetite-suppressant medication prescription if medically indicated and four energy-boosting shots. The wording matters: issuing a prescription and supplying the medicine are different services. Nothing in that list establishes that injectable semaglutide or tirzepatide is included in the $110, nor does it establish that every patient will receive an appetite suppressant.

For budgeting, ask whether the published monthly appointment schedule applies throughout your proposed care, how medication purchases align with it and what happens financially if treatment changes. The evidence uses “monthly” for both follow-up visits and semaglutide supply, but does not define a calendar-month billing date, a four-week cycle or automatic charging. Our explanation of monthly and four-week billing can help frame that question without imposing a schedule the clinic has not documented. The materials also do not state whether an extra visit between routine appointments carries another charge.

Sources: [3] [9]

Identify the semaglutide product before comparing its price

The semaglutide range is useful, but the product description needs clarification. A Spanish-language page describes subcutaneous semaglutide and advertises a formulation enhanced with glycine. Another attributes the clinic’s in-house semaglutide access to a 503b compounding pharmacy without naming that pharmacy in the supplied passage. The materials do not establish whether all advertised semaglutide contains glycine or whether the $100–$275 range refers specifically to that formulation. They also do not identify the exact presentation or quantity supplied beyond the phrase “monthly supply.”

FDA approval attaches to a specific drug product, not a clinic or pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. For a responsible comparison of compounded and approved drug prices, obtain the product name, ingredients, presentation and dispensing pharmacy before treating two prices as prices for the same thing.

Sources: [11] [7] [9] [1]

Other offerings can change the proposed bill

Texas Weight Loss advertises injectable tirzepatide alongside semaglutide, and describes oral phentermine as a medication it commonly prescribes. Its wider menu includes vitamin B-6 and NAD+ injections, supplements and other weight-management medication based on personal needs. The pricing page also lists in-house intramuscular wellness injections, including glutathione, vitamin B12, Lipoden and amino-acid blends. These offerings document a broader medical-weight-management business, not a single standardized GLP-1 subscription. The supplied evidence does not price every option or establish which would be proposed together.

Several optional-looking line items have their own published prices: energy-boosting shots cost $20 individually or $60 for four; shots marketed as “Fat Burner” cost $25 individually or $80 for four; standalone body-composition analysis costs $25. The four-shot “Fat Burner” package carries a “buy three get one free” footnote without further conditions in that block. Those are provider marketing labels, not evidence here of clinical benefit. Ask which items are included, separately charged or elective, and whether declining an injection changes the quoted appointment price. The FAQ explicitly says patients can choose not to take injections.

Sources: [7] [10] [9] [3]

Follow the service pathway from consultation to home use

The advertised starting point is a consultation at one of the clinics, where the team discusses goals, reviews medical history and outlines an individualized plan. The GLP-1 page describes an evaluation to determine whether medication may be appropriate, followed by a plan that may include nutrition guidance, lifestyle recommendations, progress monitoring and medication management. Texas Weight Loss claims 20 years of experience and six Texas locations. It presents Joseph Sleiman with MD and FAAFP credentials; this review did not independently verify those credentials or the provider’s experience claim.

The network describes locations in Austin, San Antonio and the Houston area. Its after-hours telemedicine announcement is expressly for Texas residents, but does not establish the full geographic policy for every service or explain remote-visit pricing. The FAQ permits home self-injection after training from the medical team, while another page promises monitoring and help managing side effects. Those statements do not explain whether medication is collected or shipped, who provides injection supplies, or how urgent questions are handled. Public Spanish-language pages are available, but do not confirm Spanish-language availability for every appointment or support channel.

Sources: [6] [3] [8] [11] [5]

Testing and eligibility questions belong in the quote

The clinic’s FAQ says an electrocardiogram is required for patients with risk factors such as hypertension, diabetes or high cholesterol, and for those age 50 or older. The supplied price list does not establish an EKG fee or whether that test is included elsewhere. This is a concrete reason to ask about evaluation costs beyond the standard laboratory list. It is not a reason to assume every patient will need an EKG, nor to assume the initial $150 covers one when the published inclusion list does not say so.

Medication-specific rules also need to stay separate. The FAQ states a phentermine criterion of BMI at least 30 and no comorbid condition; a separate phentermine article says certain people with heart disease, uncontrolled hypertension or a substance-misuse history may not be candidates. Those are the provider’s phentermine disclosures, not its GLP-1 eligibility policy. The GLP-1 page instead describes individualized evaluation without complete published criteria in the supplied evidence. Ask which assessment applies to the proposed medication and what the consultation costs if it ends without a prescription. Do not treat payment as evidence of eligibility.

Sources: [3] [4] [8] [9]

Obtain payment, pharmacy and exit terms before enrolling

The published visit and medication prices do not resolve insurance acceptance, claims submission, prior authorization, payment methods or financing. Nor do the supplied materials establish minimum commitments, mandatory prepayment, automatic renewal, missed-appointment charges, cancellation deadlines or refunds. These are unknown terms, not evidence that a particular restriction exists. Ask the scheduling contact for written financial terms before authorizing a charge. The pages provide appointment-scheduling calls to action, but the evidence does not document a complete billing-support process or a reliable turnaround time for answers.

A useful written quote should identify the evaluation fee, likely recurring visits, exact medication and pharmacy, dispensing or delivery charges, and the policy for unused or interrupted services. Our prepayment question checklist offers a way to organize those answers. Delivery procedures remain undocumented here. If injectable GLP-1 medication is shipped, FDA explicitly advises not using it if it arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Before shipment, clarify who handles a temperature concern, a replacement request and any related charge; the clinic’s general support promise does not answer those financial questions.

Sources: [9] [7] [11] [1]

Questions & answers

Is Texas Weight Loss’s $100–$275 semaglutide price all-inclusive?

No all-inclusive price is established. The provider describes $100–$275 as the charge for a monthly semaglutide supply depending on dosage. It separately publishes $150 initial and $110 monthly follow-up visits, and expressly states that medication is an additional charge. Ask for a quote showing which appointments apply, the exact medication price and any other required services. The evidence does not support a single total for every patient or identify which exact semaglutide formulation the range covers.

Sources: [9]
What laboratory tests are listed in the $150 first visit?

The pricing page lists a comprehensive metabolic panel, thyroid-stimulating hormone testing, a lipid panel and HbA1c, alongside consultation and body-composition analysis. It also lists four energy-boosting shots and dietary materials. Separately, the FAQ describes EKG requirements for certain risk factors and people age 50 or older. It does not establish that an EKG is included in the $150. Confirm the price of any additional testing before the appointment rather than assuming all evaluation costs are covered.

Sources: [9] [3]
Does Texas Weight Loss name its semaglutide pharmacy?

Not in the supplied passage. A Spanish-language page attributes its in-house semaglutide sourcing to a 503b compounding pharmacy, but does not identify that business. Another page describes semaglutide with glycine. These disclosures do not establish the exact formulation supplied to every patient, the priced presentation or pharmacy location. Request the dispensing pharmacy’s name and the full medication description before comparing the offer with a named approved product or another clinic’s compounded preparation.

Sources: [7] [11]
Can patients take injections at home instead of visiting for every injection?

The FAQ says patients can self-administer injections at home after training by the medical team. That supports a home-use option, not a fully remote enrollment pathway or a shipping promise. The program still describes a clinic consultation and monthly follow-up appointments. Ask how medication is obtained, whether supplies are included, what training involves and whether any follow-ups can be remote. The after-hours telemedicine announcement alone does not answer those process or pricing questions.

Sources: [3] [6]
Does the clinic publish a tirzepatide price or insurance policy?

The provider advertises tirzepatide injections, but the supplied evidence does not publish a tirzepatide price or explain insurance acceptance, medication coverage, prior authorization or claims handling. Do not substitute the semaglutide range for a tirzepatide quote. NIDDK notes that insurance coverage for weight-management medicines varies, and consultation coverage is a separate question. Confirm both the clinic’s billing practices and your plan’s benefits before assuming an advertised cash amount will be reimbursed.

Sources: [7] [9] [2]
Is there a subscription commitment or cancellation refund?

The supplied materials do not establish a minimum term, automatic renewal, cancellation deadline or refund policy. Monthly follow-up language describes the care schedule; it does not by itself prove a subscription contract. Likewise, a monthly medication supply does not establish a minimum purchasing commitment. Before paying, request the applicable agreement and ask separately about canceling appointments, stopping future charges and recovering money already paid. Permission to cancel would not, by itself, establish a right to a refund.

Sources: [3] [9]

Our assessment

Texas Weight Loss provides a useful degree of price visibility for office-based weight management: the initial evaluation has named laboratory inclusions, follow-up visits have a published fee, and semaglutide has a dosage-dependent monthly range. Its nutrition materials, monthly monitoring and home-injection training also describe more than medication access alone. The weakness is the missing connection between those disclosures. The evidence does not establish a complete treatment bill, the exact priced semaglutide formulation, a named dispensing pharmacy, tirzepatide pricing or financial exit terms. FDA approval should not be inferred for the advertised compounded preparation, and provider marketing claims should not substitute for product documentation. For a prospective patient, the next useful step is a written, itemized quote tied to the proposed care plan, with pharmacy details and cancellation terms attached. That would make this offering meaningfully comparable without assuming either that the lowest medication price is the total or that every unknown represents an extra charge.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Texas Weight Loss — faq ↗
  4. Texas Weight Loss — phentermine what to know for safe effective weight loss ↗
  5. Texas Weight Loss — es mx/weight loss supplements ↗
  6. Texas Weight Loss — official website ↗
  7. Texas Weight Loss — es mx/weight loss injections ↗
  8. Texas Weight Loss — glp 1 support ↗
  9. Texas Weight Loss — pricing ↗
  10. Texas Weight Loss — weight loss injections ↗
  11. Texas Weight Loss — es mx/how to inject your weight loss medication ↗
  12. Texas Weight Loss — how it works ↗

Continue reading